Details
Stereochemistry | RACEMIC |
Molecular Formula | C12H17NO3 |
Molecular Weight | 223.2683 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1=CC=C(NC(=O)CC(C)O)C=C1
InChI
InChIKey=LIAWQASKBFCRNR-UHFFFAOYSA-N
InChI=1S/C12H17NO3/c1-3-16-11-6-4-10(5-7-11)13-12(15)8-9(2)14/h4-7,9,14H,3,8H2,1-2H3,(H,13,15)
Molecular Formula | C12H17NO3 |
Molecular Weight | 223.2683 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionCurator's Comment: http://www.genome.jp/dbget-bin/www_bget?D01116
http://www.drugfuture.com/chemdata/bucetin.html
Curator's Comment: http://www.genome.jp/dbget-bin/www_bget?D01116
http://www.drugfuture.com/chemdata/bucetin.html
Bucetin [(3-hydroxy-p-butyrophenetidide) CAS: 1083-57-4) is a homologue to phenacetin and is used instead of phenacetin as an analgesic drug because of its lower toxicity than that of phenacetin, despite having equivalent analgesic activity when used at an appropriate dose. Dysplastic lesions of the proximal tubules were frequently seen in the males given bucetin in a dose-related fashion.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Betadid Approved UseUnknown |
|||
Sources: http://www.ncbi.nlm.nih.gov/pubmed/3479641 |
Primary | Betadid Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
[Study on Butylon, a new combined analgesic, with special reference to the analgesic potentiation between o-ethoxybenzamide and 3-hydroxy-p-burtyrophenetidide (Bucetin)]. | 1966 May 20 |
|
Studies on absorption and excretion of drug. 8. The release rate in vivo of antipyretic and analgesic drugs from commercial sugar coated tablets. | 1967 Jul |
|
Drug absorption, metabolism, and excretion. 3. Synthesis of the metabolites of bucetin (beta-hydroxybutyro-p-phenetidide). | 1968 Nov |
|
Drug absorption, metabolism, and excretion. II. Metabolism of bucetin (beta-hydroxybutyro-p-phenetidide) in rabbits. | 1968 Sep |
|
Carcinogenicity of bucetin in (C57BL/6 X C3H)F1 mice. | 1987 Nov |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 16 20:20:51 UTC 2022
by
admin
on
Fri Dec 16 20:20:51 UTC 2022
|
Record UNII |
6M7CVQ8PF8
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
N02BE74
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
||
|
WHO-VATC |
QN02BE54
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
||
|
WHO-ATC |
N02BE54
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
||
|
WHO-VATC |
QN02BE04
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
||
|
NCI_THESAURUS |
C241
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
||
|
WHO-ATC |
N02BE04
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
||
|
WHO-VATC |
QN02BE74
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1283
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
PRIMARY | |||
|
214-109-8
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
PRIMARY | |||
|
C72112
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
PRIMARY | |||
|
759243
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
PRIMARY | |||
|
413
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
PRIMARY | |||
|
1083-57-4
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
PRIMARY | |||
|
SUB05942MIG
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
PRIMARY | |||
|
Bucetin
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
PRIMARY | |||
|
DTXSID6020721
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
PRIMARY | |||
|
14130
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
PRIMARY | |||
|
320045
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
PRIMARY | |||
|
DB13278
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
PRIMARY | |||
|
CHEMBL1697856
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
PRIMARY | |||
|
M2737
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
PRIMARY | Merck Index | ||
|
6M7CVQ8PF8
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
PRIMARY | |||
|
C023637
Created by
admin on Fri Dec 16 20:20:51 UTC 2022 , Edited by admin on Fri Dec 16 20:20:51 UTC 2022
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |